| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $267.1M | +42.9% |
| R&D Expense | $38.1M | +117.3% |
| SG&A Expense | $66.2M | +42.3% |
| Operating Income | -$122.6M | -127.4% |
| Interest Expense | $12.7M | +281.1% |
| Pre-tax Income | -$136.4M | -146.2% |
| Income Tax | -$7.9M | — |
| Net Income | -$128.6M | -132.0% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $233.5M | -20.4% |
| Accounts Receivable | $111.1M | +36.7% |
| Current Assets | $358.7M | -7.0% |
| Total Assets | $1.26B | +199.1% |
| Current Liabilities | $327.4M | +302.8% |
| Total Liabilities | $573.1M | +116.0% |
| Stockholders' Equity | $690.7M | +339.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.5M | -407.0% |
| Capital Expenditures | $3.1M | -42.5% |
| Investing Cash Flow | -$506.7M | -4908.4% |
| Financing Cash Flow | $486.0M | +135.4% |
| Free Cash Flow | -$41.6M | -220.1% |